Jérôme Cros

1Camille Roussel
1Saibou Doumbia
1Pascal Hammel
Learn More
  • Jérôme Cros, Nicolas Cagnard, Kevin Woollard, Natacha Patey, Shen-Ying Zhang, Brigitte Senechal +9 others
  • 2010
Monocytes are effectors of the inflammatory response to microbes. Human CD14(+) monocytes specialize in phagocytosis and production of reactive oxygen species and secrete inflammatory cytokines in response to a broad range of microbial cues. Here, we have characterized the functions of human monocytes that lack CD14 (CD14(dim)) and express CD16. CD14(dim)(More)
Pancreatic ductal adenocarcinoma (PDAC) stands as the poorest prognostic tumor of the digestive tract, with a 5-year survival rate of less than 5 %. Therapeutic options for unresectable PDAC are extremely limited and there is a pressing need for expanded therapeutic approaches to improve current options available with gemcitabine-based regimens. With PDAC(More)
In the context of climate change, agricultural managers have the imperative to combine sufficient productivity with durability of the resources. Many studies have shown the interest of recent satellite missions as suitable tools for agricultural surveys. Nevertheless, they are not predictive methods. A system able to detect summer crops as early as possible(More)
  • Seidina A. S. Diakité, Papa Alioune Ndour, Valentine Brousse, Frederick Gay, Camille Roussel, Sylvestre Biligui +11 others
  • 2016
Sickle-cell trait (HbAS) reduces falciparum malaria risk and suppresses parasitaemia. Although several candidate mechanisms have been proposed, their epidemiological, clinical and experimental correlates have not been adequately explained. To explore the basis for generally lower parasitaemias and delayed malaria episodes in children with HbAS, it is(More)
We report four cases of acute pulmonary edema that occurred during treatment by intravenous tocolysis using nicardipine in pregnancy patients with no previous heart problems. Clinical severity justified hospitalization in intensive care unit (ICU) each time. Acute dyspnea has begun at an average of 63 hours after initiation of treatment. For all patients,(More)
  • 1